Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ali Sarabi-Asiabar
Cost-Effectiveness of Teriparatide Compared With Alendronate and Risedronate for the Treatment of Postmenopausal Osteoporosis Patients in Iran
Medical Journal of the Islamic Republic of Iran
Medicine
Related publications
A Systematic Review and Economic Evaluation of Alendronate, Etidronate, Risedronate, Raloxifene and Teriparatide for the Prevention and Treatment of Postmenopausal Osteoporosis
Health Technology Assessment
Medicine
Health Policy
Monthly Risedronate for the Treatment of Postmenopausal Osteoporosis
Pharmaceutica Analytica Acta
Pms63 - Cost-Effectiveness of Actonel® 35 Mg (Risedronate) Gastro-Resistant Tablets for the Treatment of Postmenopausal Women With Osteoporosis in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment
PLoS ONE
Multidisciplinary
PMS71 Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women in Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment Responses With Once-Weekly Teriparatide Therapy for Osteoporosis
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Pms47 - Cost-Effectiveness of Tofacitinib Compared With Adalimumab in the Treatment of Moderate to Severe Rheumatoid Arthritis in Iran
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
FRI0566 Teriparatide and Alendronate Improved Bone Loss and Hyperalgesia in a Mouse Model of Osteoporosis
Greater First Year Effectiveness Drives Favorable Cost-Effectiveness of Brand Risedronate Versus Generic or Brand Alendronate: Modeled Canadian Analysis
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
